Human Papillomavirus Vaccine Recombinant Quadrivalent

    November 2009 in “ Reactions Weekly ”
    &NA;
    Image of study
    TLDR Two women lost hair after mesotherapy for hair loss, with one having permanent and the other temporary hair loss.
    In a 2009 report, two women experienced patchy alopecia following mesotherapy treatments for androgenic alopecia. The first, a 32-year-old, received injections containing mesoglycan and developed an erythematous patch of alopecia, paraesthesias, trichodynia, and hair loss, with a marked decrease in hair density and almost no terminal anagen hair follicles on biopsy. After 3 months, she had residual scarring alopecia. The second, a 22-year-old, had four sessions with a homeopathic solution and developed erythematous patches of alopecia. Biopsy showed a prominent decrease in hair density, increased catagen follicles and telogen germinal units, and dilated infundibular ostia. She experienced complete hair regrowth after 7 months. The cause of hair loss was unclear, and no previous reports of alopecia associated with mesoglycan were found in medical databases.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 375 results

      community Looks like a real cure to the root of baldness (DHT-induced senescence) was proven earlier this year

      in Research/Science  738 upvotes 2 years ago
      A study that outlines the full model for androgenic alopecia (AGA) which links DHT to cellular senescence in dermal papilla cells, and suggests black chokeberry as a source of cyanidin 3-O-arabinoside polyphenol with potential anti-oxidant properties that could reverse this process. The post encourages reaching out to experts in anti-aging and longevity to research treatments involving the polyphenol.
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 6 months ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

    Similar Research

    5 / 1000+ results
      Alopecia Secondary to Mesotherapy

      research Alopecia Secondary to Mesotherapy

      49 citations, July 2009 in “Journal of the American Academy of Dermatology”
      Some people experienced hair loss after mesotherapy treatments for hair loss.
      Alopecia Areata: An Update

      research Alopecia Areata: An Update

      67 citations, January 2013 in “Indian Journal of Dermatology, Venereology and Leprology”
      The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.
      Mesotherapy: Myth and Reality

      research Mesotherapy: Myth and Reality

      3 citations, April 2011 in “Expert Review of Dermatology”
      Mesotherapy lacks strong evidence for effectiveness and safety, and its ingredients are not FDA-approved for subcutaneous use.